WELCOME TO OUR PRESENTATION

Topic name: Pharmaceutical Industry: An Upcoming

Source of Foreign Currency
B.Sc. Engineering Part-I, Odd Semester 2019

Department of Applied Chemistry & Chemical Engineering

University of Rajshahi
Group Member Name & I.D.
 Introduction
The pharmaceutical industry in Bangladesh is one of
the most developed technology sectors within
Bangladesh. Manufacturers produce insulin,
hormones, and cancer drugs. This sector provides
97% of the total medicinal requirement of the local
market. The industry also exports medicines to global
markets, including Europe. Pharmaceutical
companies are expanding their business with the aim
to expand the export market.
 Statistical Data
According to Export Promotion Bureau the amount of mony earned from
the export of medicine can be given by following table
Fiscal year Amount(Million USD)
2011-12 48.25
2012-13 59.82
2013-14 69.24
2014-15 72.64
2015-16 82.11
2016-17 89.17
2017-18 103.46
 Statistical Data
Amount of earning from the export of medicine
120
103.46
100
89.17
82.11
80 72.64
69.24
Currency,usd

59.82
60
48.25

40

20

0
2011-12 2012-13 2013-14 2014-15 2015-16 2016-17 2017-18
Fiscal year
 Prospect of Pharmaceutical
Industries

Bangladesh's pharmaceuticals sector will grow 15

percent year-on-year to reach $5.11 billion by 2023,
propelled by high investments by local companies as
they seek to grab a bigger share of the global market,
said a new study yesterday. By 2022, the market size
will be more than doubled to $4.44 billion from $2.02
billion now, it said.
 Problems of Export of
Pharmaceutical Products
• Restrictions of Bangladesh Bank to remit transfer hampering pharmaceutical
exports.
• Custom harassment in sending drug sample interrupts export promotion.
• Lack of bioequivalence test facility is a major limitation of pharmaceutical
export.
• Country image and production of substandard/fake drugs by some companies
hampering the acceptance of our products to international community.
• Lack of a modern drug testing laboratory is a major limitation of drug control
authority of Bangladesh that also affects pharmaceutical export.
• The regulatory authorities of importing countries are not satisfied with the status,
activities and documents of drug administration of Bangladesh.
• The regulatory authorities of importing countries are charging high registration
fees.
• Uneven registration expenses increase cost
Possible Solution to the Problems
in Exporting Medicines
• Backward integration into API
• Central bioequivalence and drug testing laboratory.
• Strengthening of Drug Regulatory Authority
• Special Economic Zone (SEZ) for Pharma
• Export incentives from government
• Capacity building in IP/regulatory and legal affairs.
• Building biosimilar capabilities
• Industry and academia collaboration
• Incentive for promoting R&D activities
• Export promotion scheme
• Infrastructure for exporting high-end pharmaceuticals
• Contract manufacturing
 Conclusion
The pharmaceutical sector of Bangladesh is the second largest export
earning sector after RMG. The country has built a solid base for this sector
to emerge as a potential sector in the upcoming days to support our
economy. The pharmaceutical companies are successful in local market
with huge import substitutions and now flourishing in the international
market mostly due to the opportunity of patent exemption by the TRIPS
(Agreement on Trade-Related Aspects of Intellectual Property Rights) until
2033. To boost up this sector’s elevation the obstacles should be reduced in
a short period of time. Some steps have already been taken by the
government, which is offering of cash incentives to the medicine exporters
and the Export Promotion Bureau (EPB) is arranging international trade
fair to attract the foreign buyers.
THANK YOU